Pal Tuya, Hull Pamela C, Koyama Tatsuki, Lammers Phillip, Martinez Denise, McArthy Jacob, Schremp Emma, Tezak Ann, Washburn Anne, Whisenant Jennifer G, Friedman Debra L
Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN, 37232, USA.
Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, 2220 Pierce Avenue, 536 Robinson Research Building, Nashville, TN, 37232, USA.
BMC Cancer. 2021 Nov 23;21(1):1262. doi: 10.1186/s12885-021-08949-4.
Despite lower cancer incidence rates, cancer mortality is higher among rural compared to urban dwellers. Patient, provider, and institutional level factors contribute to these disparities. The overarching objective of this study is to leverage the multidisciplinary, multispecialty oncology team from an academic cancer center in order to provide comprehensive cancer care at both the patient and provider levels in rural healthcare centers. Our specific aims are to: 1) evaluate the clinical effectiveness of a multi-level telehealth-based intervention consisting of provider access to molecular tumor board expertise along with patient access to a supportive care intervention to improve cancer care delivery; and 2) identify the facilitators and barriers to future larger scale dissemination and implementation of the multi-level intervention.
Coordinated by a National Cancer Institute-designated comprehensive cancer center, this study will include providers and patients across several clinics in two large healthcare systems serving rural communities. Using a telehealth-based molecular tumor board, sequencing results are reviewed, predictive and prognostic markers are discussed, and treatment plans are formulated between expert oncologists and rural providers. Simultaneously, the rural patients will be randomized to receive an evidence-based 6-week self-management supportive care program, Cancer Thriving and Surviving, versus an education attention control. Primary outcomes will be provider uptake of the molecular tumor board recommendation and patient treatment adherence. A mixed methods approach guided by the Consolidated Framework for Implementation Research that combines qualitative key informant interviews and quantitative surveys will be collected from both the patient and provider in order to identify facilitators and barriers to implementing the multi-level intervention.
The proposed study will leverage information technology-enabled, team-based care delivery models in order to deliver comprehensive, coordinated, and high-quality cancer care to rural and/or underserved populations. Simultaneous attention to institutional, provider, and patient level barriers to quality care will afford the opportunity for us to broadly share oncology expertise and develop dissemination and implementation strategies that will enhance the cancer care delivered to patients residing within underserved rural communities.
Clinicaltrials.gov , NCT04758338 . Registered 17 February 2021 - Retrospectively registered, http://www.clinicaltrials.gov/.
尽管农村地区的癌症发病率较低,但与城市居民相比,农村地区的癌症死亡率更高。患者、医疗服务提供者和机构层面的因素导致了这些差异。本研究的总体目标是利用学术癌症中心的多学科、多专业肿瘤学团队,以便在农村医疗中心为患者和医疗服务提供者提供全面的癌症护理。我们的具体目标是:1)评估基于远程医疗的多层次干预措施的临床效果,该干预措施包括医疗服务提供者能够获取分子肿瘤专家委员会的专业知识,以及患者能够获得支持性护理干预措施,以改善癌症护理的提供;2)确定未来大规模推广和实施该多层次干预措施的促进因素和障碍。
由美国国立癌症研究所指定的综合癌症中心协调,本研究将纳入两个为农村社区服务的大型医疗系统中多个诊所的医疗服务提供者和患者。使用基于远程医疗的分子肿瘤专家委员会,对测序结果进行审查,讨论预测性和预后性标志物,并由专家肿瘤学家和农村医疗服务提供者制定治疗计划。同时,农村患者将被随机分配接受一项为期6周的循证自我管理支持性护理计划“癌症茁壮成长与生存”,或接受教育关注对照。主要结局将是医疗服务提供者对分子肿瘤专家委员会建议的采纳情况以及患者的治疗依从性。将采用由实施研究综合框架指导的混合方法,结合定性关键信息访谈和定量调查,从患者和医疗服务提供者两方面收集数据,以确定实施该多层次干预措施的促进因素和障碍。
拟议的研究将利用信息技术支持的、基于团队的护理提供模式,以便为农村和/或服务不足的人群提供全面、协调和高质量的癌症护理。同时关注机构、医疗服务提供者和患者层面影响优质护理的障碍,将使我们有机会广泛分享肿瘤学专业知识,并制定推广和实施策略,以加强为居住在服务不足的农村社区的患者提供的癌症护理。
Clinicaltrials.gov,NCT04758338。于2021年2月17日注册——追溯注册,http://www.clinicaltrials.gov/ 。